The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
167 STUDIES OF LONG-TERM PROTEIN CHANGES IN<br />
RATS NEONATALLY TREATED WITH THE<br />
CYANOBACTERIAL TOXIN β-N-METHYLAMINO-L-<br />
ALANINE (BMAA) USING MALDI IMAGING MASS<br />
SPECTROMETRY.<br />
O. Karlsson, E. Roman, E. Brittebo and M. Andersson. Pharmaceutical<br />
Biosciences, Uppsala University, Uppsala, Sweden. Sponsor: M. Stigson.<br />
Most cyanobacteria (blue-green algae) found in aquatic and terrestrial environments<br />
can produce the toxin BMAA. Dietary exposure to BMAA has been suggested<br />
to be involved in the etiology <strong>of</strong> amyotrophic lateral sclerosis/Parkinsonismdementia<br />
complex. Our previous studies have revealed an uptake <strong>of</strong> BMAA in the<br />
hippocampus and striatum <strong>of</strong> neonatal mice. Furthermore, neonatal rats treated<br />
with BMAA displayed acute but transient motoric disturbances and failed to show<br />
habituation at juvenile age. In addition, neonatal BMAA administration induced<br />
long-term learning impairments in adult rats.<br />
<strong>The</strong> aim <strong>of</strong> the present study was to search for molecular correlates <strong>of</strong> changed<br />
learning behavior in the brain <strong>of</strong> the adult rats used in the behavior studies. Wistar<br />
rats were given BMAA on postnatal day 9–10 (200 or 600 mg/kg; sc injection) and<br />
Matrix Assisted Laser Desorption Ionization (MALDI) Imaging Mass<br />
Spectrometry (IMS) was used to assess regional distribution and protein levels at<br />
adult age. Primarily MALDI IMS is focused on brain structures that are important<br />
for spatial learning and memory formation, including hippocampus and striatum<br />
that were previously demonstrated to have a selective uptake after neonatal exposure.<br />
Brain sections were thaw-mounted onto MALDI compatible glass slides and<br />
picoliter-sized droplets <strong>of</strong> sinapinic acid and 2,4,-dihydroxyacetophenone matrix<br />
were deposited in arrays across the sections using a robotic microdispenser. Mass<br />
spectra were acquired from each matrix deposition on a Bruker Ultraflex II<br />
MALDI-TOF operated in linear mode. <strong>The</strong>re were more than 300 small proteins<br />
in the mass range between 2000-20 000 Da in every mass spectrum. <strong>The</strong> preliminary<br />
data evaluation revealed that the BMAA-treated groups expressed a lower level<br />
<strong>of</strong> 18 kDa Myelin basic protein (MBP) but not <strong>of</strong> the 14 kDa MBP is<strong>of</strong>orm in the<br />
striatum. Other proteins <strong>of</strong> unknown identity also demonstrated treatment-related<br />
changes and could be involved in the BMAA-induced learning impairments.<br />
168 EFFECT OF DEVELOPMENTAL CHLORPYRIFOS<br />
EXPOSURE ON ENDOCANNABINOID<br />
METABOLIZING ENZYMES IN THE BRAIN OF<br />
JUVENILE RATS.<br />
R. L. Carr and M. K. Ross. Center for Environmental Health Sciences, Mississippi<br />
State University, Mississippi State, MS.<br />
<strong>The</strong> endogenous cannabinoids 2-arachidonylglycerol (2-AG) and anandamide<br />
(AEA) play vital roles during nervous system development including regulating axonal<br />
guidance and synaptogenesis. <strong>The</strong> degradation <strong>of</strong> 2-AG and AEA is mediated<br />
by monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), respectively.<br />
Both enzymes are highly susceptible to inhibition by organophosphate<br />
compounds in vitro, and acute in vivo exposure <strong>of</strong> adult animals to the agricultural<br />
insecticide chlorpyrifos (CPS) results in moderate inhibition <strong>of</strong> both MAGL and<br />
FAAH at 30 mg/kg and elevated the levels <strong>of</strong> the endocannabinoids at 100 mg/kg.<br />
However, the effects <strong>of</strong> repeated exposure to lower levels <strong>of</strong> CPS, especially during<br />
development, on endocannabinoid metabolism in the brain is not known. To determine<br />
this, rat pups were exposed daily from days 10-16 to CPS (5 mg/kg) either<br />
orally dissolved in corn oil (PO-Oil) or subcutaneously dissolved in DMSO (SC-<br />
DMSO). A representative vehicle/route control group was present for each treatment.<br />
At 6 hrs post-exposure, the activities <strong>of</strong> acetylcholinesterase (AChE), MAGL,<br />
and FAAH were determined in the forebrain. AChE inhibition in the SC-DMSO<br />
and PO-Oil groups was 75% and 50%, respectively. No significant effect on<br />
MAGL activity was observed in either treatment group. However, FAAH activity<br />
was virtually eliminated with inhibition ranging from 93% in the PO-Oil group to<br />
100% in the SC-DMSO group. This extensive inhibition <strong>of</strong> FAAH suggests the potential<br />
for accumulation <strong>of</strong> AEA resulting in activation <strong>of</strong> endocannabinoid transmission<br />
during brain maturation. This could have implications for the appropriate<br />
development <strong>of</strong> the endocannabinoid system leading to permanent alterations in<br />
neuronal brain circuits and behavioral responses.<br />
169 PHENCYCLIDINE (PCP) INDUCED CELL DEATH AND<br />
CHANGES IN GENE EXPRESSION.<br />
F. Liu 1 , N. Sadovova 3 , X. Zou 1 , X. Zhang 1 , L. Shi 2 , L. Guo 2 , F. Qian 4 , Z.<br />
Wen 4 , T. Patterson 1 , J. Hanig 5 , M. Paule 1 , W. Slikker 1 and C. Wang 1 .<br />
1<br />
Division <strong>of</strong> Neurotoxicology, National Center for Toxicological Research, Jefferson,<br />
AR, 2<br />
Division <strong>of</strong> Systems <strong>Toxicology</strong>, National Center for Toxicological Research/U.S.<br />
Food & Drug Administration, Jefferson, AR, 3<br />
Toxicologic Pathology Associates,<br />
Jefferson, AR, 4<br />
Z-Tech, an ICF International Company at NCTR, Jefferson, AR and<br />
5<br />
5Center for Drug Evaluation and Research/U.S. Food & Drug Administration,<br />
Silver Spring, MD.<br />
Repetitive administration (perinatal) <strong>of</strong> PCP, an N-methyl-D-aspartate (NMDA)<br />
receptor antagonist, may result in cortical apoptosis and long-lasting behavioral<br />
deficits. <strong>The</strong> present study examined the potential neurotoxic effects <strong>of</strong> PCP on<br />
postnatal day (PND) 7 rat pups and the possible underlying mechanism. PND 7<br />
rats were subcutaneously administered 10 mg/kg PCP or saline (control) on PNDs<br />
7, 9, and 11, and 24 hours later the rats were sacrificed and brain tissues were harvested<br />
for RNA extraction and morphological assessments. RNA samples were collected<br />
from frontal cortical levels and hybridized to Illumina Rat Ref-12 Expression<br />
BeadChips containing 22,226 probes. <strong>The</strong> criteria used for selecting the differentially<br />
expressed genes (DEGs) were a fold-change greater than 1.4 (up or down) and<br />
a P-value less than 0.05 when comparing the PCP treatment group to the control<br />
group. Based on these criteria, 19 genes were up-regulated and 24 genes were down<br />
regulated. Among them, 6 up-regulated genes are pro-apoptotic, and 8 down-regulated<br />
genes are anti-apoptotic factors, which may have the potential to induce apoptosis.<br />
Using histochemical approaches, elevated neuronal cell death was evident in<br />
PCP-treated brains. Consistent with previous observations, DNA microarray data<br />
indicated a significant up-regulation <strong>of</strong> NMDA receptor NR1 subunit mRNA in<br />
the PCP group. <strong>The</strong>se findings support the working hypothesis that the apoptosis<br />
produced by PCP is, at least in part, through the up-regulation <strong>of</strong> NMDA receptors,<br />
which makes neurons possessing these receptors more vulnerable, after PCP<br />
washout, to the excitotoxic effects <strong>of</strong> endogenous glutamate. Supported by<br />
NCTR/NTP IAG # 244-07-0007 (E-2155).<br />
170 RECOMMENDATIONS FOR DEVELOPING<br />
ALTERNATIVE TEST METHODS FOR<br />
DEVELOPMENTAL NEUROTOXICITY.<br />
K. Cr<strong>of</strong>ton 1 , L. Buzanska 2 , S. Coecke 2 , H. Knaut 3 , P. Lein 4 , W. Mundy 1 , A.<br />
Price 2 , A. Seiler 5 and A. Goldberg 6 . 1 Integrated Systems <strong>Toxicology</strong>, U.S. EPA,<br />
Research Triangle Park, NC, 2 Joint Research Council, Ispra, Italy, 3 Skirball Institute,<br />
New York University School <strong>of</strong> Medicine, NYC, NY, 4 Molecular Biosciences, U.S.<br />
Davis, Davis, CA, 5 ZEBET, Berlin, Germany and 6 CAAT, Johns Hopkins University,<br />
Baltimore, MD.<br />
<strong>The</strong>re is great interest in developing alternative methods for developmental neurotoxicity<br />
testing (DNT) that are cost-efficient, use fewer animals and are based on<br />
current scientific knowledge <strong>of</strong> the developing nervous system. Alternative methods<br />
will require demonstration <strong>of</strong> their predictive ability as well as the development and<br />
acceptance <strong>of</strong> a strategy for data interpretation. <strong>The</strong>refore, an international group <strong>of</strong><br />
experts developed a set <strong>of</strong> recommendations to facilitate development <strong>of</strong> alternative<br />
DNT test methods. <strong>The</strong> intent <strong>of</strong> the document is to engage the research community<br />
in the development <strong>of</strong> in vitro and alternative DNT methods, to stimulate discussion<br />
and to facilitate comparative evaluations <strong>of</strong> candidate models. Definitions<br />
for endpoint, test system and test method were adopted from previously published<br />
OECD guidance documents. Fourteen criteria deemed important for DNT test<br />
method development are proposed to address issues <strong>of</strong> relevance to human neurodevelopment,<br />
specificity, sensitivity and comparison <strong>of</strong> data within and between<br />
laboratories. <strong>The</strong>se criteria are applicable to new approaches and are meant to stimulate<br />
input <strong>of</strong> new scientific knowledge into the development <strong>of</strong> alternative DNT<br />
methods. This abstract does not necessarily reflect the policy <strong>of</strong> the U.S. EPA.<br />
171 ASSESSING LATER-LIFE BEHAVIORAL PHENOTYPES<br />
IN RESPONSE TO PRENATAL EXPOSURE TO<br />
BENZOPYRENE.<br />
M. McCallister 1 , M. Maguire 1 , A. Ramesh 3 and D. B. Hood 1, 2 . 1 Center for<br />
Molecular and Behavioral Neuroscience, Meharry Medical College, Nashville, TN,<br />
2<br />
Department <strong>of</strong> Pharmacology and <strong>The</strong> Brain Institute, Vanderbilt University School<br />
<strong>of</strong> Medicine, Nashville, TN and 3 Department <strong>of</strong> Biochemistry and Cancer Biology,<br />
Meharry Medical College, Nashville, TN.<br />
Benzo(a)pyrene is an environmental contaminant that is a member <strong>of</strong> the polycyclic<br />
aromatic hydrocarbon (PAH) family. It was reported that environmental levels<br />
encountered in the air <strong>of</strong> New York City can affect child IQ scores adversely.<br />
36 SOT 2010 ANNUAL MEETING